» Articles » PMID: 20032317

Intravenous Zanamivir for Oseltamivir-resistant 2009 H1N1 Influenza

Overview
Journal N Engl J Med
Specialty General Medicine
Date 2009 Dec 25
PMID 20032317
Citations 48
Authors
Affiliations
Soon will be listed here.
Citing Articles

In Vitro Characterization of Multidrug-Resistant Influenza A(H1N1)pdm09 Viruses Carrying a Dual Neuraminidase Mutation Isolated from Immunocompromised Patients.

Takashita E, Fujisaki S, Yokoyama M, Shirakura M, Morita H, Nakamura K Pathogens. 2020; 9(9).

PMID: 32887429 PMC: 7559125. DOI: 10.3390/pathogens9090725.


Pathogenesis of pandemic H1N1 2009 influenza virus infection and the implication on management.

To K, Li I, Hung I, Cheng V, Yuen K Front Med China. 2020; 4(2):147-156.

PMID: 32214991 PMC: 7088550. DOI: 10.1007/s11684-010-0030-9.


Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.

Uyeki T, Bernstein H, Bradley J, Englund J, File T, Fry A Clin Infect Dis. 2018; 68(6):e1-e47.

PMID: 30566567 PMC: 6653685. DOI: 10.1093/cid/ciy866.


Characteristics and mortality of severe influenza cases treated with parenteral aqueous zanamivir, United Kingdom, October 2009 to January 2011.

Cleary P, Crofts J, Parry-Ford F, Chand M, Phin N Influenza Other Respir Viruses. 2018; 13(1):44-53.

PMID: 30137684 PMC: 6304314. DOI: 10.1111/irv.12603.


Pharmacodynamics, Pharmacokinetics, and Antiviral Activity of BAY 81-8781, a Novel NF-κB Inhibiting Anti-influenza Drug.

Droebner K, Haasbach E, Dudek S, Scheuch G, Nocker K, Canisius S Front Microbiol. 2017; 8:2130.

PMID: 29163418 PMC: 5673638. DOI: 10.3389/fmicb.2017.02130.